Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | -4.76% | -16.67% | +5.71% |
20/02 | Sigyn Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sigyn Therapeutics, Inc. Appoints Jerry Deciccio as Chief Financial Officer | CI |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Roberts
FOU | Founder | 71 | 19/19/19 |
James Joyce
CEO | Chief Executive Officer | 62 | 19/19/19 |
Jerry DeCiccio
DFI | Director of Finance/CFO | 67 | 12/12 |
Charlene R. Owen
COO | Chief Operating Officer | - | 01/21/01 |
Eric Lynam
CTO | Chief Tech/Sci/R&D Officer | - | 26/21/26 |
Annette Marleau
CTO | Chief Tech/Sci/R&D Officer | - | 11/23/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Joyce
CEO | Chief Executive Officer | 62 | 19/19/19 |
James W. Dorst
BRD | Director/Board Member | 69 | 10/22/10 |
Richa Nand
BRD | Director/Board Member | 50 | 10/22/10 |
Craig Roberts
FOU | Founder | 71 | 19/19/19 |
Director/Board Member | 48 | 10/22/10 |
Company contact information
Sigyn Therapeutics, Inc.
2468 Historic Decatur Road Suite 140
92106, San Diego
+
http://www.sigyntherapeutics.comSector
Chiffre d''affaires - Rate of surprise
- Stock Market
- Equities
- SIGY Stock
- Company SIGN THERPAR